Cytokinetics, Incorporated (CYTK) CEO Robert Blum on Q1 2022 Results - Earnings Call Transcript

Cytokinetics, Incorporated (NASDAQ:NASDAQ:CYTK) Q1 2022 Earnings Conference Call May 4, 2022, 04:30 PM ET Company Participants Diane Weiser - SVP of Corporate Communications and IR Robert...

Related Keywords

Madrid ,Spain ,China ,Australia ,Mizuho ,Hokkaido ,Japan ,United States ,Canada ,Raymond James ,Stuart Kupfer ,Robert Wong ,Charles Duncan ,Rob Califf ,Carter Gould ,Pete Stavropoulos ,Bob Harrington ,Serge Belanger ,Jason Butler ,Fady Malik ,Madhu Kumar ,Ji Xing ,Sean Mccutcheon ,Andrew Callos ,John Henderson ,Salim Syed ,Akash Tewari ,Piper Sandler ,Diane Weiser ,Joe Pantginis ,Robert Blum ,Dane Leone ,Yasmeen Rahimi ,Justin Kim ,Cytokinetics Incorporated ,Company Participants ,American College Of Cardiology ,Goldman Sachs ,Needham Company ,Cantor Fitzgerald ,Corporate Communications ,Barclays ,European Society Of Cardiology Heart Failure ,Conference Call May ,Chief Commercial ,Chief Medical ,Cytokinetic First Quarter ,Cytokinetic Senior Manager ,Chief Executive Officer ,Chief Commercial Officer ,Chief Medical Officer ,Chief Accounting Officer ,Ching Jaw ,Chief Financial Officer ,European Society ,Cardiology Heart Failure ,New York Heart Association Functional Class ,Cardiac Biomarkers ,Heart Failure ,Appropriate Mitigation ,Royalty Pharma ,Pat Gage ,Like Rob ,Kim Troy ,American College ,